Mercy

https://www.mercy.net/

Mercy is a non-profit Catholic healthcare organization founded in 1871 by the Sisters of Mercy. Headquartered in Chesterfield, Missouri, within Greater St. Louis, its core mission is to extend the healing ministry of Jesus by improving community health, with a particular focus on serving the poor and underserved.

The organization operates as the seventh largest Catholic health care system in the United States, encompassing more than 40 acute care and specialty hospitals, alongside over 700 physician and outpatient clinics. Mercy provides a comprehensive range of healthcare services, including primary care, specialty care, emergency services, urgent care, and various medical specialties such as cardiology, oncology, orthopedics, women's health, and behavioral health. Its services primarily extend across Missouri, Arkansas, Oklahoma, and Kansas, with additional ministry outreach programs in Texas, Louisiana, and Mississippi.

As of April 1, 2022, Steve Mackin serves as Mercy's CEO. The organization employs over 40,000 workers and more than 2,400 physicians. Recent notable developments include being awarded funding in April 2026 to enhance care for patients with chronic high blood pressure, and its CEO being recognized on a list of Great Leaders in Healthcare. Additionally, in April 2026, Newsweek ranked Mercy Birth Centers among America's Best Maternity Hospitals.

Latest updates

Mercy Secures Funding to Standardize Hypertension Care Across 91,000+ Patients

Event summary

  • Mercy, a multi-state health system, received funding from PCORI through its Health Systems Implementation Initiative (HSII).
  • The funding, approved pending review, will support a standardized, team-based hypertension care model across Mercy's system.
  • The program aims to improve hypertension management for an estimated 91,000+ patients by 2030.
  • Mercy has previously received HSII funding for weight loss and cancer symptom management programs.
  • The initiative will replace largely manual processes with automated identification and referral through the electronic health record.

The big picture

This funding signals a growing trend of health systems leveraging evidence-based practices and technology to proactively manage chronic conditions like hypertension, driven by rising healthcare costs and a focus on preventative care. PCORI’s HSII initiative represents a significant investment in translating research into clinical practice, and Mercy’s selection highlights its commitment to improving patient outcomes and operational efficiency within a large, geographically diverse health system. The program's scale – impacting over 91,000 patients – demonstrates the potential for broader adoption of similar models across the healthcare landscape.

What we're watching

Execution Risk
The success of the program hinges on Mercy's ability to integrate the new workflows across its extensive network of facilities and physician practices, potentially facing resistance or logistical challenges.
Financial Impact
While the program aims to improve outcomes, the financial sustainability of the expanded team-based care model will depend on reimbursement rates and cost efficiencies achieved during implementation.
Regulatory Scrutiny
Given PCORI's funding and focus on patient-centered research, the program's outcomes and data collection practices will likely be subject to ongoing scrutiny and potential reporting requirements.

Mercy Dominates Newsweek's Maternity Hospital Rankings

Event summary

  • Mercy hospitals secured six spots on Newsweek's 2026 'America's Best Maternity Hospitals' list.
  • Mercy is the only health system to have multiple birth centers recognized in Arkansas, Missouri, and Oklahoma.
  • Newsweek's ranking methodology incorporates hospital quality metrics, patient experience, and reputation.
  • Four Missouri-based Mercy hospitals (Jefferson, Southeast, Springfield, and St. Louis) and birthplaces in Northwest Arkansas and Oklahoma City were recognized.

The big picture

Mercy's dominance in maternity care within its regional footprint underscores the importance of reputation and patient experience in the healthcare sector. This recognition, combined with Mercy's broader scale as a $15 billion health system, strengthens its brand and potentially attracts higher-value patients. The Newsweek ranking provides a tangible asset for marketing and recruitment efforts, but also creates a benchmark for ongoing performance.

What we're watching

Competitive Response
Other regional healthcare providers will likely scrutinize Mercy's success and attempt to replicate its strategies, potentially intensifying competition for maternity patients.
Methodology Shift
Newsweek's weighting of quality metrics, patient experience, and reputation could change in future years, impacting Mercy's ranking and requiring ongoing adaptation.
Service Expansion
Mercy's comprehensive maternity care offerings, from preconception to postpartum, may drive expansion into related fertility and genetic counseling services, increasing revenue streams.

Mercy Expands Neurodevelopmental Care with $16M Center

Event summary

  • Mercy opened the Mercy Kids Center for Neurodevelopment in Chesterfield, Missouri, in late January, with a public event held April 16, 2026.
  • The new center quadruples the previous facility's size, from 12,000 to 43,000 square feet.
  • Construction was funded entirely through $16 million in grants and donations.
  • The center consolidates physical, speech, occupational, and autism therapies under one roof.
  • The expansion follows a decade of planning and commemorates the 40th anniversary of Mercy's original child development center.

The big picture

Mercy's investment in neurodevelopmental care reflects a broader trend among large health systems to expand specialized pediatric services and address unmet needs in underserved communities. The $16 million investment, while substantial, represents a relatively small portion of Mercy's overall $13 billion annual revenue, but signals a strategic commitment to a high-growth area. The success of this center will likely inform future capital allocation decisions within Mercy's extensive network.

What we're watching

Demand Dynamics
The increasing prevalence of neurodevelopmental disorders, coupled with a shortage of specialized care providers, suggests sustained demand for Mercy's services, but also potential for capacity constraints.
Funding Model
Reliance on grants and donations creates vulnerability; Mercy will need to diversify funding sources to ensure long-term operational stability and expansion.
Competitive Landscape
The consolidated, comprehensive approach could attract patients from competitors, but also invites new entrants or consolidations within the regional neurodevelopmental care market.

Mercy Adopts Novel Histotripsy for Liver Tumor Treatment

Event summary

  • Mercy Hospital St. Louis is the first in Missouri to offer histotripsy, a non-invasive tumor destruction technology.
  • The Edison® Histotripsy System uses focused sound waves to liquefy tumors without surgery, chemotherapy, or radiation.
  • Mercy is among the first 100 hospitals in the U.S. to adopt the technology, with the first patient procedure planned for late April 2026.
  • Histotripsy is currently undergoing trials for solid renal tumors and inoperable pancreatic adenocarcinoma.

The big picture

The adoption of histotripsy represents a shift towards less invasive cancer treatments, potentially disrupting traditional surgical and radiation oncology workflows. This technology aligns with the broader trend of precision medicine and personalized therapies, offering a potentially gentler alternative for patients. While still early, the technology’s success could significantly impact the competitive landscape for liver cancer treatment and beyond.

What we're watching

Adoption Rate
The speed at which other hospitals adopt histotripsy will depend on clinical trial results and reimbursement policies, potentially impacting Histosonics’ revenue projections.
Clinical Expansion
Success in treating liver tumors will likely accelerate trials for other cancer types, but the technology's efficacy across diverse tumor types remains to be seen.
Reimbursement
How insurance providers classify and reimburse for histotripsy procedures will be a key determinant of its long-term viability and Mercy's ROI on the investment.

Mercy Home Health Gains Visibility in New U.S. News Rankings

Event summary

  • Three Mercy Home Health locations (Des Peres, Landmark Parkway, and Fort Smith) received 'High Performing' designations in U.S. News & World Report's inaugural Best Home Health Agency rankings.
  • The rankings, released March 10, 2026, evaluated over 12,000 agencies, with just 17% receiving the 'Best Home Health' designation.
  • Mercy Home Health East (formerly Des Peres and Landmark Parkway) serves the St. Louis area, while Mercy Home Health Arkansas operates in Fort Smith.
  • The rankings are based on data from the Centers for Medicare & Medicaid Services, incorporating care quality and patient experience metrics.

The big picture

The introduction of U.S. News rankings in the home health sector, a market serving over 3 million patients annually, represents a shift towards greater transparency and accountability. This recognition provides a valuable marketing tool for Mercy, but also establishes a benchmark for ongoing performance. The rankings' methodology, relying on CMS data, highlights the increasing importance of data-driven quality metrics in healthcare.

What we're watching

Market Impact
The rankings' debut may drive increased patient and referral source scrutiny of home health agencies, potentially impacting market share and pricing dynamics.
Operational Alignment
Mercy's consolidation of St. Louis locations under 'Mercy Home Health East' suggests a broader strategy of operational efficiency; the impact of these changes on patient outcomes and satisfaction warrants monitoring.
Regulatory Scrutiny
Given the reliance on CMS data, any changes to CMS reporting requirements or methodology could significantly impact future rankings and agency performance.

Mercy Taps HCA Exec McGusty to Lead St. Louis Operations

Event summary

  • Tricia McGusty has been appointed President of Mercy St. Louis Communities, effective March 9, 2026.
  • McGusty previously served as COO and interim CEO at HCA Houston Healthcare Northwest.
  • Dr. David Meiners, the outgoing president, will transition to an executive advisor role.
  • A major campus renovation at Mercy Hospital St. Louis is among McGusty’s initial priorities.
  • Mercy provided over $500 million in free care and community benefits in FY2025.

The big picture

The appointment of an external executive from a competitor (HCA) signals a potential strategic shift at Mercy, possibly indicating a desire to accelerate growth or address operational challenges. This move is consistent with broader trends in the healthcare industry, where systems are increasingly seeking outside leadership to drive change and improve performance. The focus on facility renovation also highlights the ongoing need for healthcare providers to modernize infrastructure to meet evolving patient needs and technological advancements.

What we're watching

Execution Risk
McGusty’s success will hinge on her ability to integrate into Mercy’s existing culture and swiftly address the challenges of the large-scale campus renovation, potentially impacting patient flow and operational costs.
Governance Dynamics
The transition of Dr. Meiners to an advisory role warrants observation; his continued involvement could either smooth the handover or create friction depending on alignment with McGusty’s vision.
Competitive Landscape
Given McGusty’s experience at HCA, her strategies at Mercy St. Louis will be closely watched for potential shifts in competitive positioning and market share within the St. Louis region.

Mercy Rural Hospitals Recognized for Performance Amidst Sector Challenges

Event summary

  • Six of Mercy's rural hospitals across Arkansas, Missouri, and Oklahoma were recognized by Chartis' Top 100 Rural Hospitals list for 2026.
  • Mercy Hospital Washington in Missouri is being recognized for the first time, while the other hospitals have been recognized previously.
  • The Chartis Rural Hospital Performance INDEX® uses publicly available data to assess performance across operations, quality, patient perspective, and finance.
  • Mercy provided over $500 million in free care and community benefits in fiscal year 2025.

The big picture

Rural hospitals face unique challenges, including limited resources, geographic isolation, and an aging population. Mercy's recognition highlights the importance of strategic investments and operational efficiency in maintaining access to care in these underserved areas. The awards also underscore the broader trend of healthcare systems seeking to bolster their community presence and demonstrate social responsibility, particularly as regulatory pressures and consumer expectations evolve.

What we're watching

Financial Sustainability
The continued recognition of these rural hospitals will be tested as reimbursement rates and operating margins remain under pressure, requiring ongoing innovation to maintain performance.
Rural Access
How Mercy's integrated care model will adapt to evolving rural demographics and the increasing complexity of patient needs will be critical for sustaining its position.
INDEX Methodology
The reliance on publicly available data in the Chartis INDEX means the methodology itself could be subject to scrutiny and potential revisions, impacting future rankings.

Mercy Hospitals Rank Among World's Best, Highlighting Regional Healthcare Strength

Event summary

  • Four Mercy hospitals (Northwest Arkansas, Oklahoma City, Springfield, and St. Louis) were recognized as among the 'World's Best Hospitals' by Newsweek.
  • Mercy Hospital St. Louis has been recognized for eight consecutive years, while Springfield, Oklahoma City, and Northwest Arkansas have been recognized for five, three, and two years respectively.
  • Mercy St. Louis and Oklahoma City hospitals were specifically recognized for leadership in infection prevention.
  • Newsweek's ranking methodology incorporates data from medical experts, patient surveys, quality metrics, and Statista’s patient-reported outcomes.

The big picture

This recognition underscores Mercy’s position as a leading healthcare provider, particularly within the Midwest and South. The consistent accolades, especially for St. Louis, demonstrate a sustained commitment to quality and patient experience. However, the reliance on a third-party ranking system introduces a degree of external validation that may not fully reflect internal operational efficiencies or financial performance.

What we're watching

Methodology Scrutiny
The reliance on Newsweek and Statista's methodology, while providing external validation, warrants examination of potential biases or limitations in their data sources and weighting.
Regional Impact
The concentration of recognized hospitals within specific regions of Mercy’s operational footprint suggests a need to assess whether these successes are scalable or indicative of localized advantages.
Competitive Response
Other healthcare providers will likely use this recognition to bolster their own marketing and patient acquisition efforts, potentially intensifying competition for market share.

Mercy St. Louis Pioneers Hybrid Heart Procedure, Expanding Market Share

Event summary

  • Mercy St. Louis is the first and only hospital in Missouri to offer Hybrid Coronary Revascularization (HCR).
  • HCR combines traditional bypass surgery and stenting, offering a minimally invasive alternative to open-heart surgery.
  • Patient Kurtis Cox recovered significantly faster, returning to normal activities within weeks of the procedure.
  • Dr. Parth Patel, cardiothoracic surgeon at Mercy St. Louis, leads the HCR program.
  • Mercy is a $6 billion health system serving patients across five states.

The big picture

Mercy's adoption of HCR reflects a broader trend in healthcare towards minimally invasive procedures and personalized medicine. By being the first in Missouri to offer this combined approach, Mercy is positioning itself to capture market share and attract patients seeking faster recovery times and reduced risk. This move also highlights the increasing importance of specialized, team-based care models within large health systems.

What we're watching

Adoption Rate
The pace at which other Missouri hospitals and health systems adopt HCR will indicate the procedure's perceived value and Mercy's competitive moat.
Reimbursement
How insurers and Medicare/Medicaid reimburse for HCR compared to traditional bypass surgery will be a key driver of its long-term viability.
Expansion
Whether Mercy expands the HCR program to other hospitals within its network will signal confidence in its efficacy and scalability.

Mercy Appoints Google Health Vet to Drive Digital Transformation

Event summary

  • Mercy has appointed Lina Scroggins as its Chief Product Officer, effective February 2, 2026.
  • Scroggins previously held roles at Google, including shaping Google Health and leading digital transformation projects for health systems.
  • Her mandate is to simplify and connect healthcare for Mercy's patients, focusing on platforms like mercy.net and the MyMercy app.
  • Mercy is one of the 15 largest U.S. health systems, serving millions annually and providing over $500 million in community benefits in FY2025.

The big picture

The hiring of Scroggins underscores the growing recognition within the healthcare industry that digital transformation is critical for patient engagement and operational efficiency. While many health systems have dabbled in digital tools, few have appointed a dedicated executive with Scroggins’s pedigree. This move positions Mercy to potentially leapfrog competitors in the race to deliver a seamless, personalized patient experience, but also carries the risk of disruption and integration challenges.

What we're watching

Execution Risk
The success of Scroggins’s strategy hinges on her ability to translate Google’s product development methodologies into the complex, highly regulated healthcare environment, which may require significant organizational adaptation.
Governance Dynamics
The appointment signals a potential shift in Mercy's governance, prioritizing digital innovation and patient-centricity, and how this aligns with existing operational structures will be key.
Competitive Response
Other large health systems will likely observe Mercy’s digital transformation efforts closely, potentially accelerating their own investments in patient-facing technology to avoid losing market share.

Mercy Taps Humana Exec to Lead Contracting Amid Value-Based Shift

Event summary

  • Mercy has appointed Paul Davis, JD, MHA, as President of Contracting and Managed Care, effective January 19, 2026.
  • Davis previously served as National Vice President of Network Development and Contracting at Humana.
  • He succeeds David Ott, who is retiring after leading Mercy's payer strategies.
  • Davis’s focus will be on improving networks, expanding value-based care programs, and supporting Mercy’s growth.
  • Mercy is one of the 15 largest U.S. health systems, serving patients across six states and providing over $500 million in community benefits in FY2025.

The big picture

The appointment of Davis signals a strategic push by Mercy to strengthen its payer relationships and accelerate its adoption of value-based care models, a trend increasingly prevalent among large health systems facing pressure to control costs and improve patient outcomes. Davis’s background in network development and contracting at Humana suggests a focus on data-driven decision-making and a willingness to challenge traditional contracting approaches. This move is likely part of a broader industry shift towards more sophisticated payer negotiations and risk-sharing arrangements.

What we're watching

Strategic Alignment
Davis's experience at Humana suggests a focus on aligning incentives with providers, which could lead to changes in Mercy's contracting practices and potentially impact provider relationships.
Value Transition
The emphasis on expanding value-based care programs indicates Mercy is accelerating its transition away from fee-for-service, a move that will require significant operational and financial adjustments.
Leadership Shift
How Davis’s leadership style and priorities will differ from Ott’s, and the potential impact on existing payer relationships, warrants close observation.

Mercy to Participate in Large-Scale Cancer Screening Study

Event summary

  • Mercy is participating in the REACH study, a three-year clinical trial evaluating GRAIL's Galleri® multi-cancer early detection (MCED) test.
  • The study will enroll up to 50,000 Medicare beneficiaries, comparing those receiving the Galleri test with standard care.
  • Mercy was previously involved in earlier clinical studies of the Galleri test.
  • The study aims to assess the clinical impact of the Galleri test on a population at high risk for cancer, Medicare beneficiaries aged 50+.

The big picture

The study highlights the growing interest in multi-cancer early detection as a potential tool to improve outcomes for an aging population. Given that Medicare beneficiaries represent a significant portion of cancer diagnoses and mortality, the results of the REACH study could have a substantial impact on healthcare spending and patient care pathways. GRAIL's Galleri test represents a significant investment in preventative oncology, and its success hinges on demonstrating real-world clinical benefit.

What we're watching

Clinical Validation
The REACH study's results will be critical in determining the clinical utility and cost-effectiveness of multi-cancer early detection tests, potentially influencing Medicare coverage decisions.
Adoption Rate
The pace at which the Galleri test is adopted by other healthcare systems, beyond Mercy’s initial involvement, will indicate the level of confidence in its efficacy and the willingness of patients and providers to embrace it.
Regulatory Landscape
How the FDA and CMS ultimately classify and regulate MCED tests will significantly impact their accessibility and reimbursement, shaping the long-term market viability of GRAIL’s Galleri and similar products.

Mercy Appoints Internal Candidate as CFO Amidst Healthcare Financial Pressures

Event summary

  • Brian Day, previously Senior Vice President of Financial Operations and Planning, has been appointed CFO of Mercy, effective immediately.
  • Day’s appointment follows the retirement of Cheryl Matejka, who served as CFO for 19 years, concluding her tenure at the end of 2025.
  • Day has overseen over $1 billion in public debt financing during his 22-year tenure at Mercy.
  • Mercy, a $15 billion health system, provided over $500 million in free care and community benefits in fiscal year 2025.

The big picture

The appointment of an internal candidate signals a desire for continuity at Mercy, which faces ongoing challenges common to large health systems: navigating regulatory changes, managing supply chain costs, and maintaining financial stability while expanding access to care. The retirement of Matejka, who guided the organization through significant headwinds, creates a transition period that will test Day’s ability to maintain Mercy’s financial strength and strategic direction.

What we're watching

Financial Strategy
Day's focus on 'excellent care and investment' suggests a continued emphasis on value-based care models, which will require careful management of cost pressures and reimbursement rates.
Succession Risk
The internal promotion mitigates immediate disruption, but the long-term implications of Matejka’s departure and the potential loss of institutional knowledge remain to be assessed.
Debt Management
Given Day’s experience with $1 billion in public debt financing, the pace at which Mercy refinances or reduces its debt load will be a key indicator of its financial flexibility.
CID: 152